Prosecution Insights

Browse Companies Examiners Firms Draft Your Response

Last updated: August 18, 2026

Examiner: HIBBERT, CATHERINE S

Tech Center 1600 • Art Units: 1636 1658

This examiner grants 59% of resolved cases

Performance Statistics

59.3%

Allow Rate

-0.7% vs TC avg

842

Total Applications

+47.7%

Interview Lift

1402

Avg Prosecution Days

Based on 803 resolved cases, 2023–2026

Rejection Statute Breakdown

8.8%

§101 Eligibility

14.4%

§102 Novelty

29.2%

§103 Obviousness

32.7%

§112 Clarity

Currently Pending Office Actions

App #	Title	Status	Assignee
18000576	FUNGICIDAL COMPOSITIONS	Final Rejection	SYNGENTA CROP PROTECTION AG
17194177	GLP-1R AGONIST AND METHODS OF TREATMENT	Non-Final OA	The Johns Hopkins University
19051398	METHOD OF INCREASING THE FUNCTION OF AN AAV VECTOR	Non-Final OA	The Trustees of the University of Pennsylvania
18013479	GLP-1R AGONISTIC PEPTIDES WITH REDUCED ACTIVITY	Non-Final OA	SANOFI
18564639	COMPOSITION FOR PREVENTING OR TREATING VASCULAR DISEASES, CONTAINING HAPLN1	Non-Final OA	CHUNG ANG University industry Academic Cooperation Foundation
18185449	DISCOVERY OF YEATS2 YEATS DOMAIN INHIBITORS AS NOVEL ANTI-CANCER AGENTS	Non-Final OA	The University of Hong Kong
17049748	BIOMOLECULE ISOLATION AND INHIBITOR REMOVAL	Final Rejection	QIAGEN SCIENCES LLC
18276724	METHODS AND THREAPEUTIC COMBINATIONS FOR TREATING IDIOPATHIC INTRACRANIAL HYPERTENSION AND CLUSTER HEADACHES	Non-Final OA	NBO PHARMA INC.
18297914	ARGININE MODIFICATION AND CONJUGATION METHODS	Non-Final OA	Encodia, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy